ARCA biopharma, Inc. Stock Agreements
17 Contracts & Agreements
- Oruka Therapeutics, Inc. 2024 Employee Stock Purchase Plan (Filed With SEC on September 5, 2024)
- Form of Restricted Stock Notice and Restricted Stock Purchase Agreement of Oruka Therapeutics, Inc (Filed With SEC on May 14, 2024)
- Form of Stock Purchase Agreement between the Company and the Purchasers, dated as of June 2, 2020 (Filed With SEC on June 3, 2020)
- Form of Common Stock Certificate (Filed With SEC on May 8, 2019)
- ARCA biopharma, Inc. Common Stock ($0.001 par value pershare) Capital on Demand Sales Agreement (Filed With SEC on January 11, 2017)
- ARCA BIOPHARMA, INC. $20,000,000 Common Stock (par value $0.001 per share) AMENDMENT NO. 1 TO EQUITYDISTRIBUTION AGREEMENT (Filed With SEC on April 30, 2010)
- ARCA BIOPHARMA, INC. STOCK OPTION AGREEMENT (Filed With SEC on August 10, 2009)
- ARCA biopharma, Inc. NOTICE OF GRANT OF STOCK OPTION (Filed With SEC on March 27, 2009)
- ARCA biopharma, Inc. NOTICE OF GRANT OF STOCK OPTION (Filed With SEC on March 27, 2009)
- ARCA BIOPHARMA, INC. STOCK OPTION AGREEMENT (Filed With SEC on March 27, 2009)
- ARCA BIOPHARMA, INC. STOCK OPTION AGREEMENT (Filed With SEC on March 27, 2009)
- ARCA BIOPHARMA, INC. STOCK OPTION AGREEMENT (Filed With SEC on March 27, 2009)
- EMPLOYEE STOCK PURCHASEPLAN (Filed With SEC on August 8, 2005)
- EMPLOYEE STOCK PURCHASEPLAN (As amended and restated on December 14, 2004) (Filed With SEC on March 16, 2005)
- STOCK PURCHASE AGREEMENT (Filed With SEC on December 9, 2004)
- NUVELO, INC. STOCK OPTION AGREEMENT (Double Trigger Acceleration) (Filed With SEC on November 9, 2004)
- NUVELO, INC. STOCK OPTION AGREEMENT (Single Trigger Acceleration) (Filed With SEC on September 20, 2004)
